Product nameAnti-Tenascin C antibody [T2H5]
See all Tenascin C primary antibodies
DescriptionMouse monoclonal [T2H5] to Tenascin C
Tested applicationsSuitable for: IHC-P, IP, WB, ICC/IFmore details
Species reactivityReacts with: Human
Full length native protein (purified from a homogenate of a mammary tumour specimen) (Human).
- Human tonsil tissue
Tenascin is a high molecular weight, multifunctional, hexameric extracellular matrix glycoprotein expressed in association with mesenchymal epithelial interactions during development and in the neovasculature and stroma of undifferentiated tumors. It has been described under a variety of names: cytotactin, hexabrachion protein, J1, myotendinous antigen (MI) and glioma mesenchymal extracellular matrix (GMEM). The tenascin molecule is a disulfide-linked hexamer. The expression of tenascin is associated with development and growth, both normal and pathological, whereas the distribution in normal adult tissue is restricted.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
Storage bufferpH: 7.40
Preservative: 0.097% Sodium azide
Concentration information loading...
Purity>95% by SDS-PAGE
Purification notesPurified from hybridoma culture supernatant by protein A-affinity chromatography.
Primary antibody notesTenascin is a high molecular weight, multifunctional, hexameric extracellular matrix glycoprotein expressed in association with mesenchymal epithelial interactions during development and in the neovasculature and stroma of undifferentiated tumors. It has been described under a variety of names: cytotactin, hexabrachion protein, J1, myotendinous antigen (MI) and glioma mesenchymal extracellular matrix (GMEM). The tenascin molecule is a disulfide-linked hexamer. The expression of tenascin is associated with development and growth, both normal and pathological, whereas the distribution in normal adult tissue is restricted.
Light chain typeunknown
- Anti-Tenascin C antibody [EPR4219] (ab108930)
- Anti-Tenascin C antibody [EPR4219] (HRP) (ab196918)
- Anti-Tenascin C antibody [T2H5] - BSA and Azide free (ab212462)
- Anti-Tenascin C antibody [EPR4219] - Low endotoxin, Azide free (ab215369)
- Anti-Tenascin C antibody [SPM319], prediluted (ab54348)
- Anti-Tenascin C antibody [EB2] (ab88280)
Our Abpromise guarantee covers the use of ab3970 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||Use a concentration of 10 µg/ml. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.|
|IP||Use at an assay dependent concentration.|
|WB||Use at an assay dependent concentration. Detects a band of approximately 240 kDa.|
|ICC/IF||Use at an assay dependent concentration. PubMed: 20435685|
FunctionExtracellular matrix protein implicated in guidance of migrating neurons as well as axons during development, synaptic plasticity as well as neuronal regeneration. Promotes neurite outgrowth from cortical neurons grown on a monolayer of astrocytes. Ligand for integrins alpha-8/beta-1, alpha-9/beta-1, alpha-V/beta-3 and alpha-V/beta-6.
Sequence similaritiesBelongs to the tenascin family.
Contains 15 EGF-like domains.
Contains 1 fibrinogen C-terminal domain.
Contains 15 fibronectin type-III domains.
Cellular localizationSecreted > extracellular space > extracellular matrix.
- Information by UniProt
- 150 225 antibody
- Cytotactin antibody
- Glioma associated extracellular matrix antigen antibody
ab3970 staining paraffin embedded tissue sections.
Anti-Tenascin C antibody [T2H5] (ab3970) at 1 µg/ml + U2OS (Human osteosarcoma cell line) Whole Cell Lysate at 10 µg
Goat Anti-Mouse IgG H&L (HRP) preadsorbed (ab97040) at 1/5000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Observed band size: 265 kDa why is the actual band size different from the predicted?
Additional bands at: 34 kDa. We are unsure as to the identity of these extra bands.
Exposure time: 20 minutes
Tenascin C contains an exstensive number of potential glycosylation sites (SwissProt) which may explain its migration at a higher molecular weight than predicted.
This product has been referenced in:
- Molina-Molina M et al. Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells. BMC Pulm Med 18:63 (2018). Read more (PubMed: 29703175) »
- Valnegri P et al. RNF8/UBC13 ubiquitin signaling suppresses synapse formation in the mammalian brain. Nat Commun 8:1271 (2017). Read more (PubMed: 29097665) »